This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

No Significant Event

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 01/07/2020
Location: Las Vegas, NV
Subject: Consumer Technology Association Conference (Consumer Electronics Show (CES)): Digital Health Summit; Speaker: Demystifying Regulations
FDA Participant/Group: Several FDA officials and staff members
Non FDA Participant/Group: Industry, academia, government, media, and other registered participants

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

No Significant Event

Official Name: Lowell Schiller, Principal Associate Commissioner for Policy

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Acting Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name: Laura Caliguiri, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

Event Date: 01/11/2020
Location: San Francisco, CA
Subject: University of California San Francisco (UCSF) Roundtable with FDA, Pharma, and Payor Community
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives of University of California San Francisco and industry

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 01/06/2020
Location: Silver Spring, MD
Subject: Verifying Accurate, Leading-edge IVCT Development (VALID) Act
FDA Participant/Group: ELLEN FLANNERY; MARCY BUSCH; AVIS DANISHEFSKY; COURTNEY LIAS; TOBY LOWE; BRITTANY SCHUCK; JENNIFER TOMASELLO; LORIE ERIKSON; KATHERINE DONIGAN; ELIZABETH HILLEBRENNER;
Non FDA Participant/Group: Allysen Mullen, Debbie Burrell, Jeff Allard, Jonathan Cohen, Priscilla Markwood (Small Biotechnology Business Coalition);

Event Date: 01/08/2020
Location: Las Vegas, NV
Subject: Consumer Technology Association Conference (Consumer Electronics Show (CES)): Digital Health Summit; Keynote Speaker: Beyond the Tweets - FDA’s Grand Vision
FDA Participant/Group: Several FDA officials and staff members
Non FDA Participant/Group: Industry, academia, government, media, and other registered participants

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event